Company: Viewing FDA as Partner Eased Clearance of Diabetes App

Devices & Diagnostics Letter
A Palo Alto, Calif., company recently garnered FDA clearance for an update to a diabetes management app by focusing on safety and embracing a philosophy of partnering with the FDA.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00